2076975 2077203
최종편집 2024-06-24 07:03 (월)
11 pharmaceutical stocks in the KOSPI market ranked in the top 100 for monthly share price growth in February
상태바
11 pharmaceutical stocks in the KOSPI market ranked in the top 100 for monthly share price growth in February
  • Hyeokgi Lee, Newsmp
  • 승인 2022.03.06 19:10
  • 댓글 0
이 기사를 공유합니다

Ildong Pharmaceutical at 2nd by 81.71%ㆍShin Poong Pharmaceutical Co. Ltd. Pfd. Series 1 4th     by 61.00%... Shin Poong Pharmaceutical entered the top 10 by 45.19%  

Pharmaceutical stocks have regained vigor after a long time, occupying a higher place in share price growth.

According to the Korea Exchange, 11 pharmaceutical stocks were listed in the top 100, including three stocks in the top 10 in the KOSPI market in February.

In particular, Ildong Pharmaceutical posted an 81.71% increase over the past month, ranking second among 940 listed stocks in the KOSPI market.

During the same period, Shin Poong Pharmaceutical Co. Ltd. Pfd. Series 1 also rose more than 50% to 61.00%, ranking in the top 5, while Shin Poong Pharmaceutical jumped 45.19% at 7th place.

JW Pharmaceutical placed 21st with 30.65% growth, Daewon Pharmaceutical 23rd with 28.97%, and Daewoong Pharmaceutical 28th with 27.20%, leading six pharmaceutical stocks increase above 25% to the top 30.

Daewoong ranked 38th with 23.31%, JW Holdings 39th with 22.61%, JW Life Science 51st with 20.16%, Gene One Life Science 59th with 19.11%, and Bukwang Pharmaceutical 82nd with 16.98%, 11 stocks entering the top 10.

19 pharmaceutical stocks recorded double-digit growth rates, including Yuyu Pharma Inc. Pfd. Series 2 with 15.73%, Yuyu Pharma with 15.54%, Ilsung Pharmaceutical with 13.10%, Green Cross Holdings Corp. Pfd. Series 2 with 11.83%, Il-Yang Pharmaceutical with 11.80%, Samil Pharmaceutical with 11.66%, Kwang Dong Pharmaceutical with 10.45%, and Il Dong Holdings with 10.08%, ranked in the top 200 along with Yuyu Pharma Inc. Pfd. Series 1 with 9.43%.

Moreover, Dong Wha Pharm, JW Pharmaceutical Corp. Pfd. Series 2, Pharmicell, JW Pharmaceutical Corp. Pfd. Series 1, and Hanmi Pharmaceutical entered the top 300 with a share price increase of more than 7%.

Meanwhile, only six of the 59 pharmaceutical-related stocks in the KOSPI market (including preferred stocks) fell in February, including Myungmoon Pharmaceutical, Jeil Pharmaceutical, Reyon Pharmaceutical, PharmGen Science, ORIENTBIO, and SK Bioscience.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.